sj-docx-1-ine-10.1177_15910199221148551 - Supplemental material for A comparison of antiplatelet therapy during the peri- and post-operative periods following flow-diverting stent insertion for unruptured intracranial aneurysms: A systematic review

Supplemental material, sj-docx-1-ine-10.1177_15910199221148551 for A comparison of antiplatelet therapy during the peri- and post-operative periods following flow-diverting stent insertion for unruptured intracranial aneurysms: A systematic review by Agnes Lorraine Leung, Vincent Li, Laetitia Devilliers and Laetitia Hattingh in Interventional Neuroradiology</p

Phylogenetic tree of region E of the norovirus capsid.

<p>This figure is generated by using the neighbor-joining algorithm with BioNumerics software (version 5.1; Applied Maths Sint-Martens-Latem, Belgium).</p

The type of settings of outbreaks caused by GII.4 variants and non-GII.4 variants.

<p>The type of settings of outbreaks caused by GII.4 variants and non-GII.4 variants.</p

Norovirus GII.4 variants in outbreaks during July 2000 to June 2008.

<p>Norovirus GII.4 variants in outbreaks during July 2000 to June 2008.</p

Association of MRSA PFGE epidemic types with <i>spa</i>, SCC<i>mec</i>, and PVL types in Alberta from August 2009 to November 2009.

<p>Isolates with <i>spa</i> types that correspond to more than one epidemic type and require PFGE for PFGE epidemic type assignment^a, are rare or have not been previously observed in Alberta^b, are novel <i>spa</i> types^c, or could not be genotyped using PFGE^d are shown. Isolates marked with an * were SCC<i>mec</i> typed with primers from Kondo <i>et al.</i> (18); all other isolates were SCC<i>mec</i> typed using primers from Oliveira <i>et al</i>. (17).</p

Comparison of time associated with MRSA PFGE and <i>spa</i>, SCC<i>mec</i>, and PVL typing with times calculated in hours.

<p>Comparison of time associated with MRSA PFGE and <i>spa</i>, SCC<i>mec</i>, and PVL typing with times calculated in hours.</p

Routine molecular testing of MRSA isolates using the Alberta MRSA typing database from 2010 to 2012.

<p>Percentages of total isolates are given in brackets.</p

Norovirus GII reference genotypes used in this study.

<p>*Zheng et al. Virology, 2006.</p>†<p>Personal communication from the Food-borne Viruses in Europe (FBVE) and Centers for Disease Control and Prevention (CDC) in US Network.</p

A MRSA genotyping algorithm using <i>spa</i>, SCC<i>mec</i>, and PVL typing.

<p>PFGE epidemic types for MRSA isolates are assigned based on <i>spa</i>, SCC<i>mec</i>, and PVL data using the Alberta MRSA typing database. PFGE characterization is used for MRSA isolates that have rare or novel spa types, or have <i>spa</i>, SCC<i>mec</i>, and PVL combinations associated with more than a single PFGE epidemic type.</p

Distribution of SCC<i>mec</i> and PVL types in validation and post-validation isolates.

<p>Cell percent values relative to the row total are given in brackets.</p